Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 4006  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (93 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this Article

 Article Access Statistics
    Viewed1911    
    Printed52    
    Emailed0    
    PDF Downloaded93    
    Comments [Add]    

Recommend this journal

 


 
LETTER TO EDITOR
Year : 2007  |  Volume : 55  |  Issue : 2  |  Page : 174-175

Authors' reply


Department of Neurology, All India Institute of Medical Sciences, New Delhi - 110029, India

Date of Acceptance09-Feb-2007

Correspondence Address:
M V Padma
Department of Neurology, All India Institute of Medical Sciences, New Delhi - 110029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.32798

Rights and Permissions



How to cite this article:
Padma M V, Singh M B, Bhatia R, Srivastava A, Tripathi M, Shukla G, Goyal V, Singh S, Prasad K, Behari M. Authors' reply. Neurol India 2007;55:174-5

How to cite this URL:
Padma M V, Singh M B, Bhatia R, Srivastava A, Tripathi M, Shukla G, Goyal V, Singh S, Prasad K, Behari M. Authors' reply. Neurol India [serial online] 2007 [cited 2019 Oct 17];55:174-5. Available from: http://www.neurologyindia.com/text.asp?2007/55/2/174/32798


Sir,

I agree that it helps to strictly adhere to a dedicated protocol when we start any management strategy. However, practical constraints are real and cannot be wished away! In developing countries where stroke burden is felt more acutely (second commonest cause of death and disability), I strongly feel that the protocol can be modified to be more suitable to our practical concerns. Even with our best efforts we do not thrombolyze more than 2-6% of our stroke patients. With additional tests cutting into our limited resources, peculiar to the developing world and the terribly narrow therapeutic time window of opportunity, we will be able to ultimately treat even less!

No doubt there are and will be more strategies to extend the therapeutic time window; better select patients for reperfusion strategies etc. I also agree on the clinical dictum of primum non nocere (primarily do no harm), either by actively committing an act or withholding a proven therapy through inaction!

In the present clinical scenario, we at AIIMS tried to clinically identify patients who may not require additional tests for coagulation studies thereby limiting the resources and time required. Our results certainly have not been worse off for the deviations in the protocol. None of our patients who showed the hemorrhagic transformation or the small frontal bleed had any clinical deterioration. We still believe that protocols can be modified, albeit judiciously where the clinical problem is immense and resources are limited.




 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow